Cancer cells often exhibit high levels of genomic instability, characterized by frequent DSBs. NHEJ is crucial in maintaining cellular viability by repairing these breaks. However, its error-prone nature can introduce mutations, potentially driving tumorigenesis. Therefore, a fine balance in NHEJ activity is essential for cancer cells to survive without accumulating lethal levels of genomic damage.
